These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29958079)

  • 1. Genetics of guanylyl cyclase pathways in the cochlea and their influence on hearing.
    Fitzakerley JL; Trachte GJ
    Physiol Genomics; 2018 Sep; 50(9):780-806. PubMed ID: 29958079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the membrane/particulate guanylyl cyclase: From physicochemical sensors to hormone receptors.
    Takei Y
    Gen Comp Endocrinol; 2022 Jan; 315():113797. PubMed ID: 33957096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of the NO/cGMP-pathway in the cochlea of guinea pigs.
    Michel O; Hess A; Bloch W; Stennert E; Su J; Addicks K
    Hear Res; 1999 Jul; 133(1-2):1-9. PubMed ID: 10416859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
    Hamad AM; Range S; Holland E; Knox AJ
    Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.
    Piggott LA; Hassell KA; Berkova Z; Morris AP; Silberbach M; Rich TC
    J Gen Physiol; 2006 Jul; 128(1):3-14. PubMed ID: 16769793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanylyl Cyclase-cGMP Signaling Pathway in Melanocytes: Differential Effects of Altered Gravity in Non-Metastatic and Metastatic Cells.
    Ivanova K; Hemmersbach R
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term.
    Telfer JF; Itoh H; Thomson AJ; Norman JE; Nakao K; Campa JS; Poston L; Tribe RM; Magness RR
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5934-43. PubMed ID: 11739467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.
    Dangel O; Mergia E; Karlisch K; Groneberg D; Koesling D; Friebe A
    J Thromb Haemost; 2010 Jun; 8(6):1343-52. PubMed ID: 20149081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is next in nitric oxide research? From cardiovascular system to cancer biology.
    Bian K; Murad F
    Nitric Oxide; 2014 Dec; 43():3-7. PubMed ID: 25153032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction.
    Teunissen CE; Steinbusch HW; Markerink-van Ittersum M ; De Bruijn C ; Axer H; De Vente J
    Brain Res Dev Brain Res; 2000 Dec; 125(1-2):99-115. PubMed ID: 11154766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation.
    Bice JS; Burley DS; Baxter GF
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):269-82. PubMed ID: 24572031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cGMP signalling in auditory processing in health and disease.
    Marchetta P; Rüttiger L; Hobbs AJ; Singer W; Knipper M
    Br J Pharmacol; 2022 Jun; 179(11):2378-2393. PubMed ID: 33768519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
    Baltrons MA; García A
    J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk.
    Wobst J; Rumpf PM; Dang TA; Segura-Puimedon M; Erdmann J; Schunkert H
    Circ J; 2015; 79(3):463-9. PubMed ID: 25746521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of natriuretic peptides and their activation of particulate guanylate cyclase and nitric oxide synthase in the retina.
    Blute TA; Lee HK; Huffmaster T; Haverkamp S; Eldred WD
    J Comp Neurol; 2000 Sep; 424(4):689-700. PubMed ID: 10931490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylene blue, a soluble guanylyl cyclase inhibitor, reduces the sevoflurane minimum alveolar anesthetic concentration and decreases the brain cyclic guanosine monophosphate content in rats.
    Masaki E; Kondo I
    Anesth Analg; 1999 Aug; 89(2):484-9. PubMed ID: 10439772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis between cyclic GMP and cyclic AMP signalling in human sperm.
    Willipinski-Stapelfeldt B; Lübberstedt J; Stelter S; Vogt K; Mukhopadhyay AK; Müller D
    Mol Hum Reprod; 2004 Jul; 10(7):543-52. PubMed ID: 15121877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and regulation of soluble guanylate cyclase.
    Derbyshire ER; Marletta MA
    Annu Rev Biochem; 2012; 81():533-59. PubMed ID: 22404633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
    Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
    Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanylate cyclase and the .NO/cGMP signaling pathway.
    Denninger JW; Marletta MA
    Biochim Biophys Acta; 1999 May; 1411(2-3):334-50. PubMed ID: 10320667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.